Integration of multi-omics analysis reveals metabolic alterations of B lymphocytes in systemic lupus erythematosus.

B lymphocytes MOFA Metabolomics Multi-omics Systemic lupus erythematosus

Journal

Clinical immunology (Orlando, Fla.)
ISSN: 1521-7035
Titre abrégé: Clin Immunol
Pays: United States
ID NLM: 100883537

Informations de publication

Date de publication:
10 May 2024
Historique:
received: 20 03 2024
revised: 25 04 2024
accepted: 03 05 2024
medline: 13 5 2024
pubmed: 13 5 2024
entrez: 12 5 2024
Statut: aheadofprint

Résumé

To link changes in the B-cell transcriptome from systemic lupus erythematosus (SLE) patients with those in their macroenvironment, including cellular and fluidic components. Analysis was performed on 363 patients and 508 controls, encompassing transcriptomics, metabolomics, and clinical data. B-cell and whole-blood transcriptomes were analysed using DESeq and GSEA. Plasma and urine metabolomics peak changes were quantified and annotated using Ceu Mass Mediator database. Common sources of variation were identified using MOFA integration analysis. Cellular macroenvironment was enriched in cytokines, stress responses, lipidic synthesis/mobility pathways and nucleotide degradation. B cells shared these pathways, except nucleotide degradation diverted to nucleotide salvage pathway, and distinct glycosylation, LPA receptors and Schlafen proteins. B cells showed metabolic changes shared with their macroenvironment and unique changes directly or indirectly induced by IFN-α signalling. This study underscores the importance of understanding the interplay between B cells and their macroenvironment in SLE pathology.

Identifiants

pubmed: 38735509
pii: S1521-6616(24)00352-8
doi: 10.1016/j.clim.2024.110243
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

110243

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors have declared that no conflict of interest exists.

Auteurs

Cristian Iperi (C)

LBAI, UMR1227, Univ Brest, Inserm, Brest, France.

Álvaro Fernández-Ochoa (Á)

Department of Analytical Chemistry, University of Granada, Granada, Spain.

Jacques-Olivier Pers (JO)

LBAI, UMR1227, Univ Brest, Inserm, Brest, France.

Guillermo Barturen (G)

GENYO, Centre for Genomics and Oncological Research Pfizer, University of Granada, Andalusian Regional Government, PTS Granada, Granada, Spain; Department of Genetics, Faculty of Sciences, University of Granada, Granada, Spain.

Marta Alarcón-Riquelme (M)

GENYO, Centre for Genomics and Oncological Research Pfizer, University of Granada, Andalusian Regional Government, PTS Granada, Granada, Spain; Institute for Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

Rosa Quirantes-Piné (R)

Research and Development of Functional Food Centre (CIDAF), Health Science Technological Park, Granada, Spain.

Isabel Borrás-Linares (I)

Department of Analytical Chemistry, University of Granada, Granada, Spain.

Antonio Segura-Carretero (A)

Department of Analytical Chemistry, University of Granada, Granada, Spain.

Divi Cornec (D)

LBAI, UMR1227, Univ Brest, Inserm, Brest, France.

Anne Bordon (A)

LBAI, UMR1227, Univ Brest, Inserm, Brest, France.

Christophe Jamin (C)

LBAI, UMR1227, Univ Brest, Inserm, Brest, France. Electronic address: christophe.jamin@univ-brest.fr.

Classifications MeSH